Home > Request Information
Title:
Asgard Therapeutics Selects Exothera to Bring their Viral Vector-based Immunotherapy Candidate AT-108 to Clinical Trial Stage
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh